Virological features of hepatitis C virus infection in patients with liver diseases in a high risk region for hepatocellular carcinoma in China
我国肝细胞癌高发地区肝病患者丙型肝炎病毒感染的病毒学特征
基本信息
- 批准号:05670480
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Hepatitis C virus (HCV) is an important causative agent for hepatocellular carcinoma (HCC) in Western countries and Japan. On the other hand, the inshore area of the Yangtze River is known to have one of the highest incidences of HCC in China. Therefore, to obtain information on the association between HCC and the genomic characteristics of HCV isolates present in this region, we investigated the prevalence and the genomic heterogeneity of HCV in patients with chronic liver disease and HCC in this region. Most of such patients were infected by hepatitis B virus (HBV), but the incidence of anti-HCV and HCV-RNA were very low, observed with 0.7% in donor bloods, and 11.6% in patients with chronic liver diseases. Moreover, our results reveraled a high prevalence of genotype II,a genotype II,a similarity of Chinese and Japanses HCV isolates, and a tendency for more nucleotide (nt) substitutions in the HCV core gene in HCC patients than in those substitutions in the HCV core gene in HCC patients than in those with chronic hepatitis. In addition, nt substitutions were unevenly scattered along the genome with a cluster of missense mutations and transversions in the second hydrophilic domain from the 5'end of the core region. The rates of the occurrence of missense mutations and transversions were greater in the clustering variable region (CVR) than in the other core region. These findings suggested that the mutations occurring in this CVR may be responsible for a selective pressure from the host immune system, and closely related with progress of liver disease to HCC.
丙型肝炎病毒(HCV)是西方国家和日本肝细胞癌(HCC)的重要病原体。另一方面,长江沿岸地区是中国肝癌发病率最高的地区之一。因此,为了获得 HCC 与该地区 HCV 分离株基因组特征之间关联的信息,我们调查了该地区慢性肝病和 HCC 患者中 HCV 的患病率和基因组异质性。此类患者大多感染乙型肝炎病毒(HBV),但抗HCV和HCV-RNA的发生率很低,在供血中为0.7%,在慢性肝病患者中为11.6%。此外,我们的结果显示,HCC 患者的基因型 II、基因型 II、中国和日本 HCV 分离株的相似性以及 HCC 患者 HCV 核心基因中核苷酸 (nt) 取代的趋势高于慢性肝炎患者。此外,nt 取代沿着基因组分布不均匀,在核心区域 5' 端的第二个亲水结构域中存在一系列错义突变和颠换。聚类可变区(CVR)中错义突变和颠换的发生率高于其他核心区。这些发现表明,该CVR中发生的突变可能是来自宿主免疫系统的选择性压力的原因,并且与肝病进展为HCC密切相关。
项目成果
期刊论文数量(76)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ito S: "Epidemiological characteristics of the incidence of hepatitis C virus(C100-3)antibodies in patients with liver diseases in the inshore area of the Yangtze river." J.Gastroenterol.Hepatology. 8. 232-237 (1993)
伊藤S:“长江近岸地区肝病患者丙型肝炎病毒(C100-3)抗体发生情况的流行病学特征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Honda H: "Prevalence of HCV-antibodies and HCV-RNA in donor blood in Tokushima prefecture." Tokushima J.Exp.Med.41. 9-15 (1994)
Honda H:“德岛县捐献血液中 HCV 抗体和 HCV-RNA 的流行率。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ito S: "HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody." J Gastroenterol Hepatol. 9. 19-25 (1994)
Ito S:“HCV 感染及其在接受 HCV (C100-3) 抗体筛查的血液接受者中的临床特征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
本田 浩仁: "C型肝炎のIFN療法における精神的副作用について." Pharma.Medica.11. 173-174 (1993)
Hirohito Honda:“干扰素治疗丙型肝炎的心理副作用。Pharma.Medica.173-174 (1993)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Horikita M: "Differences in the entire nucleotide sequence between hepatitis B virus gcnomes from carriers positive for antibody to hepatitis B e antigen with and without active disease" J.Med.Virol.44. 96-103 (1994)
Horikita M:“患有或不患有活动性疾病的乙型肝炎 e 抗原抗体阳性携带者的乙型肝炎病毒基因组之间整个核苷酸序列的差异”J.Med.Virol.44。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ITO Susumu其他文献
ITO Susumu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ITO Susumu', 18)}}的其他基金
A Nationwide Survey of Nursery Schooling and Parental Employment in Children with Epilepsy or Febrile Seizures
全国范围内癫痫或热性惊厥儿童的幼儿园教育和家长就业调查
- 批准号:
20K02683 - 财政年份:2020
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mutations of the core gene sequence of HCV from patients with hepatocellular carcinoma in China and Japan
中国和日本肝癌患者HCV核心基因序列突变
- 批准号:
11695087 - 财政年份:1999
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel diagnosis method for minutecancer by infrared fluorescence endoscopy using fluorescence-emitting antibody by infrared ray excitation.
开发利用红外线激发的荧光发射抗体的红外荧光内窥镜诊断微小癌症的新方法。
- 批准号:
08457168 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
EXPERIMENTAL-THEORETICAL STUDY OF COGNITIVE AND SOCIAL FACTERS IN THE QUESTION GENERATION
问题生成中认知和社会因素的实验理论研究
- 批准号:
04610035 - 财政年份:1992
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Re-investigate of the mogage system
重新研究莫加吉系统
- 批准号:
61301062 - 财政年份:1986
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
相似海外基金
Dissecting the roles of iron and hemojuvelin in hepatocellular carcinoma
剖析铁和血幼素在肝细胞癌中的作用
- 批准号:
478251 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Operating Grants
Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
肌少症的影响以及通过免疫治疗耐药机制创建新的治疗靶点对肝细胞癌的影响
- 批准号:
23K08106 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of transcatheter arterial embolization for controlling hypoxia in hepatocellular carcinoma
经导管动脉栓塞控制肝细胞癌缺氧的研究进展
- 批准号:
23K07075 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NASH-肝细胞癌免疫治疗反应的决定因素
- 批准号:
10735947 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Targeting Ischemia-Induced Autophagy Dependence in hepatocellular Carcinoma through Image-guided Locoregional Therapy
通过图像引导局部治疗靶向肝细胞癌中缺血诱导的自噬依赖性
- 批准号:
10585078 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Investigating the Metabolic Role of Vagal Insulin Signaling in Hepatocellular Carcinoma
研究迷走神经胰岛素信号在肝细胞癌中的代谢作用
- 批准号:
495140 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Miscellaneous Programs
Impact of TA-HEV expression on tumor microenvironment in hepatocellular carcinoma
TA-HEV表达对肝细胞癌肿瘤微环境的影响
- 批准号:
23K19513 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌融合癌蛋白治疗靶向中心
- 批准号:
10826323 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Define the oncogenic role of Plk1 during hepatocellular carcinoma development using a genetically modified mouse model
使用转基因小鼠模型定义 Plk1 在肝细胞癌发展过程中的致癌作用
- 批准号:
10729603 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
一种图像引导免疫治疗和热疗装置,用于克服晚期肝细胞癌的肿瘤免疫障碍
- 批准号:
10585715 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别: